Event:	2016 Annual Meeting of Stockholders of Anavex Life Sciences Corp.
Date/Time:	Friday, May 6, 2016 10:00 a.m. ET
Location:	Offices of K & L Gates LLP, 599 Lexington Avenue, New York, NY 10022

Related Posts

Anavex Life Sciences Announces Notice of Allowance for U.S. Patent Application with Expanding Claims Covering ANAVEX®2-73 (blarcamesine) for the Treatment of Rett Syndrome and other Neurodevelopmental Disorders
November 30, 2020

Anavex Life Sciences to Present at the Evercore ISI 3rd Annual HealthCONx Conference
November 25, 2020

Proof of Concept Controlled Phase 2 Clinical Trial Data Evaluating ANAVEX®2-73 (blarcamesine) in Parkinson’s Disease Dementia Presented at CTAD 2020 Conference
November 6, 2020

Anavex Life Sciences Announces Positive Results from Proof of Concept controlled Phase 2 Clinical Trial Evaluating ANAVEX®2-73 (blarcamesine) in Parkinson’s Disease Dementia
October 15, 2020